Clinical Trial Update: The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher Stent [Phase 4]

View source ↗

Summary

The BRIDGE Registry evaluates the safety and efficacy of the Bx Cypher sirolimus-eluting stent in patients with coronary artery disease in a Phase 4 setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Bx Cypher Stent (sirolimus-eluting stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED